841 results on '"El‐Chami, Mikhael"'
Search Results
2. Sex-based outcomes of subcutaneous implantable cardioverter-defibrillator and impact of surgical technique
3. A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: 12-Month results from the Micra AV post-approval registry
4. A Patch Wearable Cardioverter-Defibrillator for Patients at Risk of Sudden Cardiac Arrest
5. Evaluation of the in vivo chemical reactivity of a novel copolymer insulation on cardiac leads in a single-center study
6. Electrocardiographic predictors of atrial mechanical sensing in leadless pacemakers
7. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication
8. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial
9. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association
10. Procedural and long-term outcomes of tunneled transvenous leads
11. Managing superior vena cava syndrome in patients with cardiac implantable electronic device leads: Strategies and considerations
12. Accurate detection of lead malfunction from ECG-derived bipolar pacing stimulus amplitude
13. Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare population
14. Safety of same-day discharge after lead extraction procedures
15. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association
16. Impact of Age on Subcutaneous Implantable Cardioverter-Defibrillator in a Large Patient Cohort: Mid-Term Follow-Up
17. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
18. Abstract 17552: Pre-Existing Right Ventricular Lead Performance After Transcatheter Tricuspid Valve Replacements (TTVR)?
19. Abstract 14849: Impact of Intravenous Heparin Bolus on Outcomes of Leadless Pacemaker Implantation
20. Abstract 14021: Micra VR Leadless vs. Single-Chamber Transvenous Pacing Outcomes in the Medicare Advantage Population
21. Abstract 14011: Micra AV Leadless vs. Dual-Chamber Transvenous Pacing Outcomes Among Patients With End-Stage Renal Disease in the Medicare Population
22. Abstract 12244: Gender Differences in Leadless Pacemaker Peri-Procedural Adverse Events, Long-Term Device Functions, and Clinical Outcomes
23. The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease
24. Leadless Pacing: Where We Currently Stand and What the Future Holds
25. Septal Bipolar Ablation to Prevent Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Implantation
26. Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study
27. Recurrence of new-onset post-operative AF after cardiac surgery: detected by implantable loop recorders: A systematic review and Meta-analysis
28. Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval Study
29. Temporal trends of device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients with underlying kidney disease
30. Diagnostic Pacing Maneuvers for Supraventricular Tachycardia Discrimination: a Taxonomic Approach
31. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
32. Rising burden of cardiac arrest– and heart failure–related mortality in the United States from 1999 to 2020
33. Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry
34. Palpitations
35. Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients
36. Ablation of manifest septal accessory pathways: a single-center experience
37. Abstract 13416: Evaluation of Risk Factors for Pacemaker After Tavr Among Patients With a Pre-Existing Right Bundle Branch Block
38. Abstract 13220: Real-World Analysis of the Electrical Performance and Projected Longevity of Leadless Ventricular Pacemakers
39. Abstract 12195: Accurate Detection of Lead Malfunction Based on Ekg-Derived Bipolar Pacing Stimulus Amplitude
40. Abstract 10532: Physician Interpretation and Characterization of Intracardiac Electrograms at the Time of Non-Cardiac Death
41. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
42. A Predictive Model for the Long-Term Electrical Performance of a Leadless Transcatheter Pacemaker
43. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke
44. Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker
45. 1-Year Prospective Evaluation of Clinical Outcomes and Shocks: The Subcutaneous ICD Post Approval Study
46. Chronic kidney disease and transvenous cardiac implantable electronic device infection—is there an impact on healthcare utilization, costs, disease progression, and mortality?
47. Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation.
48. Outcomes of tricuspid regurgitation after lead extraction.
49. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study
50. Percutaneous approaches for retrieval of an embolized or malpositioned left atrial appendage closure device: A multicenter experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.